The Patent Finder
NB

Nortiva Bio, Inc.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

12 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2037
Next term end
11
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Encapsulation of Gastric Residence Systems (US 11,793,751) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 18, 2026

What they patent

The 5 largest of its 11 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 11,576,859Gastric Residence Systems for Sustained Release of Therapeutic Agents and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 12,109,305Materials Architecture for Gastric Residence Systems
In force
 · High confidence
In forceHigh confidence
US 11,992,552Geometric Configurations for Gastric Residence Systems
In force
 · High confidence
In forceHigh confidence
US 11,576,866Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
In force
 · High confidence
In forceHigh confidence
US 12,268,776Encapsulation of Gastric Residence Systems
In force
 · High confidence
In forceHigh confidence
US 12,023,406Gastric Residence Systems with Release Rate-Modulating Films
In force
 · Medium confidence
In forceMedium confidence
US 11,793,751Encapsulation of Gastric Residence Systems
In force
 · High confidence
In forceHigh confidence
US 12,142,158Stomach Simulating Device
In force
 · High confidence
In forceHigh confidence
US 12,447,130Capsules and Capsule Coatings for Gastric Residence Dosage Forms
In force
 · High confidence
In forceHigh confidence
US 12,582,608Coatings for Gastric Residence Dosage Forms
In force
 · High confidence
In forceHigh confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
Also on record, not counted in the 12: 14 applications pending · 3 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited